Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans: an exploratory single center pragmatic open label non-randomized pilot clinical trial with matched controls

By sjmartinez • March 12, 2024

Chen K, Jackson NJ, Kelesidis T. Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans: an exploratory single center pragmatic open label non-randomized pilot clinical trial with matched controls. EBioMedicine. 2024 Mar 7:105042. doi: 10.1016/j.ebiom.2024.105042. Epub ahead of print. PMID: 38471990.

Tags: Antiviral treatment, clinical trials, covid-19, General Internal Medicine, Mitochondrial antioxidants, Post-exposure prophylaxis, Publications, SARS-CoV-2 infection, Translational research

Discontinuation of statins by patient and physician sex: An observational study

Watanabe A, Miyamoto Y, Ueyama HA, Gotanda H, Slipczuk L, Inoue K, Secemsky E, Laham R, Bhatt DL, Tsugawa Y, Kuno T. Discontinuation of statins[...]

Orbital Plasmacytoma as the Initial Presentation of Multiple Myeloma: A Case Report

Panossian A, Verhaegh T, Namavar AA. Orbital Plasmacytoma as the Initial Presentation of Multiple Myeloma: A Case Report. Cureus. 2026 Jan 24;18(1):e102225. doi: 10.7759/cureus.102225. PMID:[...]

Advancing Climate Mitigation, Adaptation, and Equity Simultaneously: The Transformative Potential of Investments in Gender Equality

Heymann J, Sprague A, Oduro AD, Grzesik-Mourad L. Advancing Climate Mitigation, Adaptation, and Equity Simultaneously: The Transformative Potential of Investments in Gender Equality. Public Health[...]